Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis.
Resistance to chemotherapy remains a major obstacle in cancer therapy. This study aimed to evaluate the molecular mechanism and efficacy of honokiol in inducing apoptosis and enhancing paclitaxel chemotherapy in pre-clinical multi-drug resistant (MDR) cancer models, including lineage-derived human M...
Main Authors: | Xu Wang, Jonathan J Beitler, Hong Wang, Michael J Lee, Wen Huang, Lydia Koenig, Sreenivas Nannapaneni, A R M Ruhul Amin, Michael Bonner, Hyung Ju C Shin, Zhuo Georgia Chen, Jack L Arbiser, Dong M Shin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3934844?pdf=render |
Similar Items
-
Erratum to: Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis
by: Arumugam Nagalingam, et al.
Published: (2017-03-01) -
Biodegradable polymeric micelles coencapsulating paclitaxel and honokiol: a strategy for breast cancer therapy in vitro and in vivo
by: Wang N, et al.
Published: (2017-02-01) -
Effect of honokiol on the induction of drug-metabolizing enzymes in human hepatocytes
by: Cho YY, et al.
Published: (2014-11-01) -
Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/β-Catenin Signaling and Apoptosis Induction
by: Chih-Jung Yao, et al.
Published: (2013-01-01) -
Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol
by: Hongjing Zang, et al.
Published: (2020-04-01)